![]() |
||||||
|
![]() | |
![]() | |
![]() | Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples |
![]() | |
![]() | |
![]() | The effects of the RNA editing to the stability of the RNA structures |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Editing gene: ANXA1 (CAeditome ID:301) |
Gene summary for ANXA1 |
![]() |
Gene information | Gene symbol | ANXA1 | Gene ID | 301 |
Gene name | annexin A1 | |
Synonyms | ANX1|LPC1 | |
Cytomap | 9q21.13 | |
Type of gene | protein-coding | |
Description | annexin A1annexin I (lipocortin I)annexin-1calpactin IIcalpactin-2chromobindin-9epididymis secretory sperm binding proteinphospholipase A2 inhibitory protein | |
Modification date | 20210518 | |
UniProtAcc | P04083 | |
Context | - 33948376(New insight into the role of ANXA1 in melanoma progression: involvement of stromal expression in dissemination) |
![]() |
Top |
RNA A-to-I events for ANXA1 |
![]() |
![]() |
![]() |
![]() |
![]() |
CAediting_689995(73154459, +), CAediting_689996(73154491, +), CAediting_689997(73154515, +), CAediting_689998(73154538, +), CAediting_689999(73154556, +), CAediting_690000(73154565, +), CAediting_690001(73154578, +), CAediting_690002(73154613, +), CAediting_690003(73154622, +), CAediting_690004(73154626, +), CAediting_690005(73154639, +), CAediting_690006(73154648, +), CAediting_690007(73154660, +), CAediting_690008(73154661, +), CAediting_690009(73154674, +), CAediting_690010(73154677, +), CAediting_690011(73154678, +), CAediting_690012(73154686, +), CAediting_690013(73154701, +), CAediting_690014(73154726, +), CAediting_690015(73157385, +), CAediting_690016(73157429, +), CAediting_690017(73157434, +), CAediting_690018(73157452, +), CAediting_690019(73157453, +), CAediting_690020(73157454, +), CAediting_690021(73157468, +), CAediting_690022(73157478, +), CAediting_690023(73157489, +), CAediting_690024(73157493, +), CAediting_690025(73157494, +), CAediting_690026(73157495, +), CAediting_690027(73157496, +), CAediting_690028(73157498, +), CAediting_690029(73157501, +), CAediting_690030(73157502, +), CAediting_690031(73157503, +), CAediting_690032(73157504, +), CAediting_690033(73157533, +), CAediting_690034(73157534, +), CAediting_690035(73157539, +), CAediting_690036(73157560, +), CAediting_690037(73157566, +), CAediting_690038(73157574, +), CAediting_690039(73157575, +), CAediting_690040(73157611, +), |
Top |
RNA editing positional annotations for ANXA1 using Annovar |
![]() |
CAeditome ID | Position | Variant type | ENST | NTchange | AAchange | SIFT_score | Polyphen2_HVAR_score | PROVEAN_pred |
![]() |
CAeditome ID | Position | Variant type |
CAediting_689995 | chr9_73154459_+ | ncRNA_intronic |
CAediting_689996 | chr9_73154491_+ | ncRNA_intronic |
CAediting_689997 | chr9_73154515_+ | ncRNA_intronic |
CAediting_689998 | chr9_73154538_+ | ncRNA_intronic |
CAediting_689999 | chr9_73154556_+ | ncRNA_intronic |
CAediting_690000 | chr9_73154565_+ | ncRNA_intronic |
CAediting_690001 | chr9_73154578_+ | ncRNA_intronic |
CAediting_690002 | chr9_73154613_+ | ncRNA_intronic |
CAediting_690003 | chr9_73154622_+ | ncRNA_intronic |
CAediting_690004 | chr9_73154626_+ | ncRNA_intronic |
CAediting_690005 | chr9_73154639_+ | ncRNA_intronic |
CAediting_690006 | chr9_73154648_+ | ncRNA_intronic |
CAediting_690007 | chr9_73154660_+ | ncRNA_intronic |
CAediting_690008 | chr9_73154661_+ | ncRNA_intronic |
CAediting_690009 | chr9_73154674_+ | ncRNA_intronic |
CAediting_690010 | chr9_73154677_+ | ncRNA_intronic |
CAediting_690011 | chr9_73154678_+ | ncRNA_intronic |
CAediting_690012 | chr9_73154686_+ | ncRNA_intronic |
CAediting_690013 | chr9_73154701_+ | ncRNA_intronic |
CAediting_690014 | chr9_73154726_+ | ncRNA_intronic |
CAediting_690015 | chr9_73157385_+ | ncRNA_intronic |
CAediting_690016 | chr9_73157429_+ | ncRNA_intronic |
CAediting_690017 | chr9_73157434_+ | ncRNA_intronic |
CAediting_690018 | chr9_73157452_+ | ncRNA_intronic |
CAediting_690019 | chr9_73157453_+ | ncRNA_intronic |
CAediting_690020 | chr9_73157454_+ | ncRNA_intronic |
CAediting_690021 | chr9_73157468_+ | ncRNA_intronic |
CAediting_690022 | chr9_73157478_+ | ncRNA_intronic |
CAediting_690023 | chr9_73157489_+ | ncRNA_intronic |
CAediting_690024 | chr9_73157493_+ | ncRNA_intronic |
CAediting_690025 | chr9_73157494_+ | ncRNA_intronic |
CAediting_690026 | chr9_73157495_+ | ncRNA_intronic |
CAediting_690027 | chr9_73157496_+ | ncRNA_intronic |
CAediting_690028 | chr9_73157498_+ | ncRNA_intronic |
CAediting_690029 | chr9_73157501_+ | ncRNA_intronic |
CAediting_690030 | chr9_73157502_+ | ncRNA_intronic |
CAediting_690031 | chr9_73157503_+ | ncRNA_intronic |
CAediting_690032 | chr9_73157504_+ | ncRNA_intronic |
CAediting_690033 | chr9_73157533_+ | ncRNA_intronic |
CAediting_690034 | chr9_73157534_+ | ncRNA_intronic |
CAediting_690035 | chr9_73157539_+ | ncRNA_intronic |
CAediting_690036 | chr9_73157560_+ | ncRNA_intronic |
CAediting_690037 | chr9_73157566_+ | ncRNA_intronic |
CAediting_690038 | chr9_73157574_+ | ncRNA_intronic |
CAediting_690039 | chr9_73157575_+ | ncRNA_intronic |
CAediting_690040 | chr9_73157611_+ | ncRNA_intronic |
![]() |
CAeditome ID | Position | Repeat family | Repeat sub family | Repeat name |
CAediting_689995 | chr9_73154459_+ | SINE | Alu | AluSz6 |
CAediting_689996 | chr9_73154491_+ | SINE | Alu | AluSz6 |
CAediting_689997 | chr9_73154515_+ | SINE | Alu | AluSz6 |
CAediting_689998 | chr9_73154538_+ | SINE | Alu | AluSz6 |
CAediting_689999 | chr9_73154556_+ | SINE | Alu | AluSz6 |
CAediting_690000 | chr9_73154565_+ | SINE | Alu | AluSz6 |
CAediting_690001 | chr9_73154578_+ | SINE | Alu | AluSz6 |
CAediting_690002 | chr9_73154613_+ | SINE | Alu | AluSz6 |
CAediting_690003 | chr9_73154622_+ | SINE | Alu | AluSz6 |
CAediting_690004 | chr9_73154626_+ | SINE | Alu | AluSz6 |
CAediting_690005 | chr9_73154639_+ | SINE | Alu | AluSz6 |
CAediting_690006 | chr9_73154648_+ | SINE | Alu | AluSz6 |
CAediting_690007 | chr9_73154660_+ | SINE | Alu | AluSz6 |
CAediting_690008 | chr9_73154661_+ | SINE | Alu | AluSz6 |
CAediting_690009 | chr9_73154674_+ | SINE | Alu | AluSz6 |
CAediting_690010 | chr9_73154677_+ | SINE | Alu | AluSz6 |
CAediting_690011 | chr9_73154678_+ | SINE | Alu | AluSz6 |
CAediting_690012 | chr9_73154686_+ | SINE | Alu | AluSz6 |
CAediting_690013 | chr9_73154701_+ | SINE | Alu | AluSz6 |
CAediting_690014 | chr9_73154726_+ | SINE | Alu | AluSz6 |
CAediting_690015 | chr9_73157385_+ | SINE | Alu | AluSx1 |
CAediting_690016 | chr9_73157429_+ | SINE | Alu | AluSx1 |
CAediting_690017 | chr9_73157434_+ | SINE | Alu | AluSx1 |
CAediting_690018 | chr9_73157452_+ | SINE | Alu | AluSx1 |
CAediting_690019 | chr9_73157453_+ | SINE | Alu | AluSx1 |
CAediting_690020 | chr9_73157454_+ | SINE | Alu | AluSx1 |
CAediting_690021 | chr9_73157468_+ | SINE | Alu | AluSx1 |
CAediting_690022 | chr9_73157478_+ | SINE | Alu | AluSx1 |
CAediting_690023 | chr9_73157489_+ | SINE | Alu | AluSx1 |
CAediting_690024 | chr9_73157493_+ | SINE | Alu | AluSx1 |
CAediting_690025 | chr9_73157494_+ | SINE | Alu | AluSx1 |
CAediting_690026 | chr9_73157495_+ | SINE | Alu | AluSx1 |
CAediting_690027 | chr9_73157496_+ | SINE | Alu | AluSx1 |
CAediting_690028 | chr9_73157498_+ | SINE | Alu | AluSx1 |
CAediting_690029 | chr9_73157501_+ | SINE | Alu | AluSx1 |
CAediting_690030 | chr9_73157502_+ | SINE | Alu | AluSx1 |
CAediting_690031 | chr9_73157503_+ | SINE | Alu | AluSx1 |
CAediting_690032 | chr9_73157504_+ | SINE | Alu | AluSx1 |
CAediting_690033 | chr9_73157533_+ | SINE | Alu | AluSx1 |
CAediting_690034 | chr9_73157534_+ | SINE | Alu | AluSx1 |
CAediting_690035 | chr9_73157539_+ | SINE | Alu | AluSx1 |
CAediting_690036 | chr9_73157560_+ | SINE | Alu | AluSx1 |
CAediting_690037 | chr9_73157566_+ | SINE | Alu | AluSx1 |
CAediting_690038 | chr9_73157574_+ | SINE | Alu | AluSx1 |
CAediting_690039 | chr9_73157575_+ | SINE | Alu | AluSx1 |
CAediting_690040 | chr9_73157611_+ | SINE | Alu | AluSx1 |
Top |
RNA A-to-I editing events in the alternative splicing sites for ANXA1 |
![]() |
AStype | CAeditomID | Editing position | AS position | AS direction | Exonic location | Wildtype sequence | Wildtype splicing strength | RNA edited sequence | RNA edited splicing strength |
ES | CAediting_689995 | chr9_73154459_+ | 73154440:73154462 | 3SS | 0+1i | TTCTTTCTTTCTTCCCGACAGAG | -8.25 | TTCTTTCTTTCTTCCCGACGGAG | 0.5 |
MEX_2 | CAediting_689995 | chr9_73154459_+ | 73154440:73154462 | 3SS | 0+1i | TTCTTTCTTTCTTCCCGACAGAG | -8.25 | TTCTTTCTTTCTTCCCGACGGAG | 0.5 |
ES | CAediting_689998 | chr9_73154538_+ | 73154531:73154539 | 5SS | 0+5i | TGGGTTCAA | -10.77 | TGGGTTCGA | -3.14 |
ES | CAediting_689998 | chr9_73154538_+ | 73154537:73154545 | 5SS | 2+0i | CAAGTGATT | 0.45 | CGAGTGATT | -1.81 |
IR | CAediting_689998 | chr9_73154538_+ | 73154531:73154539 | 5SS | 0+5i | TGGGTTCAA | -10.77 | TGGGTTCGA | -3.14 |
IR | CAediting_689998 | chr9_73154538_+ | 73154537:73154545 | 5SS | 2+0i | CAAGTGATT | 0.45 | CGAGTGATT | -1.81 |
MEX_2 | CAediting_689998 | chr9_73154538_+ | 73154531:73154539 | 5SS | 0+5i | TGGGTTCAA | -10.77 | TGGGTTCGA | -3.14 |
MEX_2 | CAediting_689998 | chr9_73154538_+ | 73154537:73154545 | 5SS | 2+0i | CAAGTGATT | 0.45 | CGAGTGATT | -1.81 |
ES | CAediting_690003 | chr9_73154622_+ | 73154617:73154625 | 5SS | 0+3i | TTGGTAGAG | -1.36 | TTGGTGGAG | -6.9 |
IR | CAediting_690003 | chr9_73154622_+ | 73154617:73154625 | 5SS | 0+3i | TTGGTAGAG | -1.36 | TTGGTGGAG | -6.9 |
MEX_2 | CAediting_690003 | chr9_73154622_+ | 73154617:73154625 | 5SS | 0+3i | TTGGTAGAG | -1.36 | TTGGTGGAG | -6.9 |
ES | CAediting_690009 | chr9_73154674_+ | 73154672:73154680 | 5SS | 1+0i | CAAGTAATC | 0.66 | CAGGTAATC | 6.99 |
IR | CAediting_690009 | chr9_73154674_+ | 73154672:73154680 | 5SS | 1+0i | CAAGTAATC | 0.66 | CAGGTAATC | 6.99 |
MEX_2 | CAediting_690009 | chr9_73154674_+ | 73154672:73154680 | 5SS | 1+0i | CAAGTAATC | 0.66 | CAGGTAATC | 6.99 |
ES | CAediting_690010 | chr9_73154677_+ | 73154672:73154680 | 5SS | 0+3i | CAAGTAATC | 0.66 | CAAGTGATC | -2.84 |
IR | CAediting_690010 | chr9_73154677_+ | 73154672:73154680 | 5SS | 0+3i | CAAGTAATC | 0.66 | CAAGTGATC | -2.84 |
MEX_2 | CAediting_690010 | chr9_73154677_+ | 73154672:73154680 | 5SS | 0+3i | CAAGTAATC | 0.66 | CAAGTGATC | -2.84 |
ES | CAediting_690011 | chr9_73154678_+ | 73154672:73154680 | 5SS | 0+4i | CAAGTAATC | 0.66 | CAAGTAGTC | -3.19 |
IR | CAediting_690011 | chr9_73154678_+ | 73154672:73154680 | 5SS | 0+4i | CAAGTAATC | 0.66 | CAAGTAGTC | -3.19 |
MEX_2 | CAediting_690011 | chr9_73154678_+ | 73154672:73154680 | 5SS | 0+4i | CAAGTAATC | 0.66 | CAAGTAGTC | -3.19 |
![]() |
![]() |
![]() |
![]() |
Top |
Differntial gene expression between RNA A-to-I edited versus non-edited samples for ANXA1 |
![]() * The grey color means N/A. |
![]() |
![]() |
![]() |
![]() * Click on the image to enlarge it in a new window. |
OV.CAediting_690015.ENSG00000135046.ANXA1.png ![]() |
Top |
Protein coding region RNA A-to-I editings for ANXA1 |
![]() * Click on the image to enlarge it in a new window. |
Top |
The effects of the RNA editing to the miRNA binding sites for ANXA1 |
**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page. |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
Top |
The effects of the RNA editing to the stability of the RNA structures for ANXA1 |
![]() * Click on the image to enlarge it in a new window. |
ENST | ENST type | RNA structure without RNA A-to-I editing. | RNA structure with RNA A-to-I editing. |
![]() |
CAeditom_ID | ENST | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
Top |
Relation with ADAR for ANXA1 |
![]() |
Cancer | CAeditomID | position | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
Top |
Relation with cancer stages for ANXA1 |
![]() |
Cancer | Stage_type | CAeditomID | position | P-val | Coeff. |
Top |
Relation with survival for ANXA1 |
![]() |
Cancer | CAeditomID | position | KMpvalue | Coxpvalue | CoxHR |
ESCA | CAediting_690015 | chr9_73157385_+ | 0.0235594979155357 | 0.0471856 | 9.30567 |
Top |
RelatedDrugs for ANXA1 |
![]() (DrugBank Version 5.1.8 2021-01-03) |
Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
ANXA1 | P04083 | DB00288 | Amcinonide | Annexin A1 | SmallMoleculeDrug | approved |
ANXA1 | P04083 | DB01013 | Clobetasol propionate | Annexin A1 | SmallMoleculeDrug | approved |
ANXA1 | P04083 | DB01222 | Budesonide | Annexin A1 | SmallMoleculeDrug | approved |
ANXA1 | P04083 | DB00591 | Fluocinolone acetonide | Annexin A1 | SmallMoleculeDrug | approved|investigational|vet_approved |
ANXA1 | P04083 | DB01234 | Dexamethasone | Annexin A1 | SmallMoleculeDrug | approved|investigational|vet_approved |
ANXA1 | P04083 | DB14541 | Hydrocortisone cypionate | Annexin A1 | SmallMoleculeDrug | approved|investigational|vet_approved |
ANXA1 | P04083 | DB14649 | Dexamethasone acetate | Annexin A1 | SmallMoleculeDrug | approved|investigational|vet_approved |
ANXA1 | P04083 | DB00741 | Hydrocortisone | Annexin A1 | SmallMoleculeDrug | approved|vet_approved |
ANXA1 | P04083 | DB00959 | Methylprednisolone | Annexin A1 | SmallMoleculeDrug | approved|vet_approved |
ANXA1 | P04083 | DB14539 | Hydrocortisone acetate | Annexin A1 | SmallMoleculeDrug | approved|vet_approved |
ANXA1 | P04083 | DB14540 | Hydrocortisone butyrate | Annexin A1 | SmallMoleculeDrug | approved|vet_approved |
ANXA1 | P04083 | DB14542 | Hydrocortisone phosphate | Annexin A1 | SmallMoleculeDrug | approved|vet_approved |
ANXA1 | P04083 | DB14543 | Hydrocortisone probutate | Annexin A1 | SmallMoleculeDrug | approved|vet_approved |
ANXA1 | P04083 | DB14544 | Hydrocortisone valerate | Annexin A1 | SmallMoleculeDrug | approved|vet_approved |
ANXA1 | P04083 | DB14631 | Prednisolone phosphate | Annexin A1 | SmallMoleculeDrug | approved|vet_approved |
ANXA1 | P04083 | DB14669 | Betamethasone phosphate | Annexin A1 | SmallMoleculeDrug | approved|vet_approved |
ANXA1 | P04083 | DB14538 | Hydrocortisone aceponate | Annexin A1 | SmallMoleculeDrug | experimental|vet_approved |
Top |
RelatedDiseases for ANXA1 |
![]() (DisGeNet 7.0) |
Gene | Disease ID | Disease name | # pubmeds | Source |
ANXA1 | C0024667 | Animal Mammary Neoplasms | 3 | CTD_human |
ANXA1 | C1257925 | Mammary Carcinoma, Animal | 3 | CTD_human |
ANXA1 | C0007097 | Carcinoma | 2 | CTD_human |
ANXA1 | C0024668 | Mammary Neoplasms, Experimental | 2 | CTD_human |
ANXA1 | C0205696 | Anaplastic carcinoma | 2 | CTD_human |
ANXA1 | C0205697 | Carcinoma, Spindle-Cell | 2 | CTD_human |
ANXA1 | C0205698 | Undifferentiated carcinoma | 2 | CTD_human |
ANXA1 | C0205699 | Carcinomatosis | 2 | CTD_human |
ANXA1 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
ANXA1 | C0020538 | Hypertensive disease | 1 | CTD_human |
ANXA1 | C0022658 | Kidney Diseases | 1 | CTD_human |
ANXA1 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
ANXA1 | C0024232 | Lymphatic Metastasis | 1 | CTD_human |
ANXA1 | C0026640 | Mouth Neoplasms | 1 | CTD_human |
ANXA1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
ANXA1 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
ANXA1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
ANXA1 | C0038354 | Stomach Diseases | 1 | CTD_human |
ANXA1 | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
ANXA1 | C0153381 | Malignant neoplasm of mouth | 1 | CTD_human |
ANXA1 | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
ANXA1 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
ANXA1 | C0376634 | Craniofacial Abnormalities | 1 | CTD_human |